Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice. Read more about Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database. Read more about The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery. Read more about Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery.
The importance of considering competing risks in recurrence analysis of intracranial meningioma. Read more about The importance of considering competing risks in recurrence analysis of intracranial meningioma.
Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty. Read more about Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
Preoperative assessment of eloquence in neurosurgery: a systematic review. Read more about Preoperative assessment of eloquence in neurosurgery: a systematic review.
Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors. Read more about Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors.
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. Read more about Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
Palliative care referral across the disease trajectory in high-grade glioma. Read more about Palliative care referral across the disease trajectory in high-grade glioma.
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449. Read more about ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
